Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Seagate Technology Holdings PLC (STX) vs Twist Bioscience Corp (TWST) Price & Performance

Seagate Technology Holdings PLCTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Seagate Technology Holdings PLC vs Twist Bioscience Corp — how do they compare? Seagate Technology Holdings PLC trades at $781.4 (market cap $176.19B), while Twist Bioscience Corp trades at $152.84 (market cap $10.08B). The key difference: Seagate Technology Holdings PLC is far larger — about 17.5× Twist Bioscience Corp's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Seagate Technology Holdings PLC for 41 Days and Twist Bioscience Corp for 27 Days on average.

STXTWST
Market Cap
$176.19B$10.08B
Volume
5,061,8754,229,037
Sector
TechnologyHealth
52-Week High
$1.09K$205.00
52-Week Low
$211.63$25.45
Typical Hold Time
41 Days27 Days
Enterprise Value
$178.34B$10.01B
Dividend Yield
0.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Seagate Technology Holdings PLC

Seagate Technology (STX) trades at $807.34, up 0.21% with recent volatility driven by AI storage competition concerns. The stock shows strong profitability with 26.11% net margin and 371.53% ROE, though valuation ratios appear elevated (P/E 55.74, P/B 81.31). Recent earnings consistently beat expectations, with Q2 2026 EPS of $5.71 surpassing the $5.10 estimate. Technical indicators show bearish momentum with support at $794 and resistance at $816.

Outlook remains cautiously optimistic given strong AI-driven storage demand and analyst consensus price target of $1,130. Key risks include increased competition from Toshiba's planned production expansion and potential margin compression. The company's negative shareholder equity and high debt levels warrant monitoring, though projected 2026 revenue growth to $12.2B with $3.2B net income suggests continued operational strength.

Twist Bioscience Corp

TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.

The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

STX
90% Buy10% Sell
Avg holding period · 41 Days
TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Seagate Technology Holdings PLC

Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital

Read more on STX →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →